Fig. 3From: Prerequisites to improve surgical cytoreduction in FIGO stage III/IV epithelial ovarian cancer and subsequent clinical ramificationsProgression-free-survival analysed by baseline, transition and evaluation groups reflecting different time framesBack to article page